Vesilute 20 mg

Vesilute is a synthetic bioactive dipeptide belonging to the bioregulatory peptide family. It is studied for its regulatory effects on urinary system tissues, particularly the bladder and prostate, through modulation of cellular gene expression and tissue-specific signaling pathways.

Research interest in Vesilute has focused on urinary tissue homeostasis, regulation of sterile inflammatory responses, prostate and bladder microcirculation, and age-related degenerative changes within urological research models.

(Khavinson et al., 2024 — Urology).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

Vesilute Overview

Vesilute is a low–molecular weight regulatory peptide characterized by a core glutamic acid–aspartic acid sequence. Due to its minimal structure, it is studied for its ability to influence epigenetic regulation, chromatin organization, and gene expression patterns in urinary system tissues.

Unlike conventional pharmacological agents, Vesilute functions as a signaling modulator rather than a direct inhibitor, making it a valuable research compound for investigating controlled tissue regulation and organ-specific cellular balance.